Product Information
BALZIVA 28 TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.3232 per EA under NDC 00555903458. Its NADAC has been published 657 times since Nov 28, 2013.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555903458
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA076238On Market Since
10/16/2006
Price Statistics
The NADAC for BALZIVA 28 TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 59.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3232 per EA |
|---|---|
| All-time high | $0.9162 (Feb 11, 2015) |
| All-time low | $0.2566 (Nov 20, 2024) |
| 52-week high | $0.4040 |
| 52-week low | $0.2982 |
| Median price | $0.5177 |
| Average price | $0.5344 |
| Largest weekly change | +60.7% (May 20, 2020) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BALZIVA 28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BALZIVA 28 TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.3232 per EA (NDC 00555903458), effective Jun 24, 2026.
How has the price of BALZIVA 28 TABLET changed over time?
Over the history we have for it, the NADAC for BALZIVA 28 TABLET has declined 59.5%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BALZIVA 28 TABLET?
Since Nov 28, 2013, the NADAC for BALZIVA 28 TABLET has ranged from a low of $0.2566 (Nov 20, 2024) to a high of $0.9162 (Feb 11, 2015), with a median of $0.5177 per EA.
Are there cheaper alternatives to BALZIVA 28 TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, NYLIA 1-35 28 TABLET, is $0.2063 per EA — about 36% below BALZIVA 28 TABLET.
Who manufactures BALZIVA 28 TABLET?
BALZIVA 28 TABLET (NDC 00555903458) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification